20031103
 Business Brief -- Teva Pharmaceutical Industries: Net Jumped 63% in 3rd Period Amid Stronger Profit Margin   The Wall Street Journal,  Nov 4, 2003  Generic-drug company Teva Pharmaceutical Industries Inc. posted a 63% jump in third-quarter profit on strong sales. Teva, based in Jerusalem, reported net income of $157 million, or 53 cents a share, compared with $96.3 million, or 36 cents a share, a year earlier.   
